Akumin (AKU) Stock Price, News & Analysis

Company Overview

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.13 to $0.36
• 52-Week Range: N/A
• Volume: 8.54 million shs
• Average Volume: 1.38 million shs
• Market Capitalization: $26.32 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AKU Stock Analysis - Frequently Asked Questions

How were Akumin's earnings last quarter?

Akumin Inc. (NASDAQ:AKU) posted its quarterly earnings results on Monday, December, 13th. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.43) by $0.41. The company had revenue of $108.18 million for the quarter, compared to the consensus estimate of $109.25 million. Akumin had a negative net margin of 30.56% and a negative trailing twelve-month return on equity of 167.86%.

What other stocks do shareholders of Akumin own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Akumin investors own include Labor Smart (LTNC), NVIDIA (NVDA), Processa Pharmaceuticals (PCSA), Acrivon Therapeutics (ACRV), Canopy Growth (CGC), Aeva Technologies (AEVA) and AST SpaceMobile (ASTS).

Company Calendar

• Last Earnings: 12/13/2021
• Today: 5/24/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical laboratories
• Sub-Industry: N/A
• Current Symbol: NASDAQ:AKU
• CIK: 1776197
• Web: www.akumin.com
• Phone: (844) 730-0050
• Fax: N/A
• Employees: 3,631
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.52)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-156,760,000.00
• Net Margins: -30.56%
• Pretax Margin: -28.78%
• Return on Equity: -167.86%
• Return on Assets: -7.81%

Debt

• Debt-to-Equity Ratio: 17.02
• Current Ratio: 0.99
• Quick Ratio: 0.99

Sales & Book Value

• Annual Sales: $749.63 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.24 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 91,170,000
• Free Float: 72,473,000
• Market Cap: $26.32 million
• Optionable: Not Optionable
• Beta: -0.72